BioNTech SE Tech Stack

BioNTech SE uses 8 technology products and services including SAS, Aprimo, Dell, and more. Explore BioNTech SE's tech stack below.

  • SAS
    Business Intelligence
  • Aprimo
    Digital Asset Management
  • Dell
    IT Infrastructure
  • Windows Server
    Operating Systems
  • JavaScript
    Programming Languages
  • Base SAS
    Software As A Service
  • AspenTech
    Supply Chain Management
  • ProvenExpert
    Widgets

Media & News

BioNTech SE's Email Address Formats

BioNTech SE uses at least 4 format(s):
BioNTech SE Email FormatsExamplePercentage
first.last@biontech.deJohn.Doe@biontech.de
39%
first.last@biontech.deJohn.Doe@biontech.de
35%
last_first@biontech.deDoe_John@biontech.de
13%
f.last@biontech.deJ.Doe@biontech.de
13%

Frequently Asked Questions

Where is BioNTech SE's headquarters located?

Minus sign iconPlus sign icon
BioNTech SE's main headquarters is located at An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is BioNTech SE's phone number?

Minus sign iconPlus sign icon
You can contact BioNTech SE's main corporate office by phone at +49-6131-90840. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioNTech SE's stock symbol?

Minus sign iconPlus sign icon
BioNTech SE is a publicly traded company; the company's stock symbol is BNTX.

What is BioNTech SE's official website and social media links?

Minus sign iconPlus sign icon
BioNTech SE's official website is biontech.de and has social profiles on LinkedIn.

How much revenue does BioNTech SE generate?

Minus sign iconPlus sign icon
As of March 2024, BioNTech SE's annual revenue reached $750M.

What is BioNTech SE's SIC code NAICS code?

Minus sign iconPlus sign icon
BioNTech SE's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioNTech SE have currently?

Minus sign iconPlus sign icon
As of March 2024, BioNTech SE has approximately 4.3K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer & Co-Founder: U. S.Chief Operating Officer: S. P.Vice President Global Commercial And General Manager: M. B.. Explore BioNTech SE's employee directory with LeadIQ.

What industry does BioNTech SE belong to?

Minus sign iconPlus sign icon
BioNTech SE operates in the Biotechnology Research industry.

What technology does BioNTech SE use?

Minus sign iconPlus sign icon
BioNTech SE's tech stack includes SASAprimoDellWindows ServerJavaScriptBase SASAspenTechProvenExpert.

What is BioNTech SE's email format?

Minus sign iconPlus sign icon
BioNTech SE's email format typically follows the pattern of first.last@biontech.de. Find more BioNTech SE email formats with LeadIQ.

How much funding has BioNTech SE raised to date?

Minus sign iconPlus sign icon
As of March 2024, BioNTech SE has raised $1.7B in funding. The last funding round occurred on Sep 15, 2020 for $450M.

When was BioNTech SE founded?

Minus sign iconPlus sign icon
BioNTech SE was founded in 2008.
BioNTech SE

BioNTech SE

Biotechnology ResearchRhineland-Palatinate, Germany1001-5000 Employees

At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. 

To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing in parallel our own state-of-the-art manufacturing processes to complement our drug development platforms.

We were founded in 2008 in Mainz, Germany and have been driven to become the leading global biotechnology company for individualized cancer medicine. We have over 20 product candidates in development, 8 candidates in 9 ongoing clinical trials, treated over 250 patients across 17 tumor types and supported by more than 1100 employees. 

As we prove the value of our approach in the clinic, we continue to build a network of world-class corporate and scientific collaborators, manufacturing and team required to bring individualized treatments to patients worldwide.

To learn more about us, visit https://biontech.de/

Our privacy statement can be found here: https://www.biontech.com/int/en/home/data-privacy-statement.html

Section iconCompany Overview

Headquarters
An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE
Phone number
+49-6131-90840
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BNTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
1001-5000

Section iconFunding & Financials

  • $1.7B

    BioNTech SE has raised a total of $1.7B of funding over 7 rounds. Their latest funding round was raised on Sep 15, 2020 in the amount of $450Mas a government funding.

  • $100M$1B

    BioNTech SE's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $1.7B

    BioNTech SE has raised a total of $1.7B of funding over 7 rounds. Their latest funding round was raised on Sep 15, 2020 in the amount of $450Mas a government funding.

  • $100M$1B

    BioNTech SE's revenue is in the range of $100M$1B

© LeadIQ, Inc. All rights reserved.